ERIS Lifesciences Ltd: Financial Statements & Historical Data

COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 8 October 2026, 8:19 am +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,146₹ per share

Reported P/E24.2Times

Book value per share282₹ per share

Reported ROCE14.1 %%

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 8 October 2026, 8:19 am +05:30. Not a live quote.

Measure	Stored figure
Market Cap	15,897 Cr.
Current Price	1,146
High / Low	1,740/1,141
Stock P/E	24.2
Book Value	282
Dividend Yield	0.63 %
ROCE	14.1 %
ROE	18.7 %
Face Value	1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
ERIS Lifesciences Ltd	15,897 Cr.	1,146	1,740/1,141	24.2	282	0.63 %	14.1 %	18.7 %	1.00
Natco Pharma Ltd	16,145 Cr.	824	1,217/786	14.1	470	0.61 %	17.4 %	17.1 %	2.00
Jubilant Pharmova Ltd	15,525 Cr.	975	1,185/784	40.0	445	0.51 %	8.99 %	6.53 %	1.00
Alembic Pharmaceuticals Ltd	16,389 Cr.	834	998/635	22.0	289	1.44 %	12.6 %	13.4 %	2.00
Astrazeneca Pharma India Ltd	14,795 Cr.	5,918	9,850/5,802	85.3	349	0.61 %	29.3 %	23.3 %	2.00
Industry Average	17,601.46 Cr	1,249.61		54.90	211.24	0.39%	26.16%	16.59%	6.06

All Competitor Stocks of ERIS Lifesciences Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	467	505	486	551	720	741	727	705	773	792	807	757	873
Expenses	297	324	311	402	470	477	477	453	496	504	526	484	577
Operating Profit	170	181	176	148	250	265	250	252	277	288	282	272	296
OPM %	36%	36%	36%	27%	35%	36%	34%	36%	36%	36%	35%	36%	34%
Other Income	1	3	4	15	2	5	4	8	4	3	-17	2	2
Interest	17	16	18	33	60	59	57	54	49	50	49	46	47
Depreciation	41	42	46	54	76	80	81	77	71	69	70	70	72
Profit before tax	112	126	116	77	116	129	116	129	161	173	145	159	179
Tax %	17%	3%	12%	-4%	22%	25%	25%	21%	22%	22%	25%	-75%	20%
Net Profit	94	122	101	80	90	96	87	102	125	134	109	279	143
EPS in Rs	6.98	9.07	7.55	5.22	6.12	6.73	6.15	6.89	8.66	8.82	7.32	20.33	10.28

Last Updated: September 29, 2026, 10:42 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 8, 2026, 8:19 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	509	546	597	750	856	982	1,074	1,212	1,347	1,685	2,009	2,894	3,129	3,230
Expenses	414	427	425	480	533	637	702	781	858	1,146	1,332	1,876	2,009	2,092
Operating Profit	95	118	172	269	322	345	372	431	489	539	677	1,018	1,120	1,138
OPM %	19%	22%	29%	36%	38%	35%	35%	36%	36%	32%	34%	35%	36%	35%
Other Income	9	7	3	25	26	31	12	9	22	9	22	18	-9	-9
Interest	0	0	0	1	11	23	2	2	4	26	85	231	193	191
Depreciation	5	16	20	23	26	36	50	43	65	117	183	315	280	281
Profit before tax	98	109	154	270	312	317	331	394	442	405	431	489	639	657
Tax %	28%	18%	13%	9%	6%	8%	11%	10%	8%	8%	8%	23%	-1%
Net Profit	71	89	135	247	295	291	297	355	406	374	397	375	648	666
EPS in Rs	5,121.45	6,489.45	9,714.18	17.95	21.39	21.15	21.84	26.16	29.88	28.10	28.82	25.84	44.72	46.75
Dividend Payout %	0%	0%	63%	0%	0%	0%	13%	21%	20%	26%	0%	28%	16%

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	25.35%	51.69%	82.96%	19.43%	-1.36%	2.06%	19.53%	14.37%	-7.88%	6.15%	-5.54%	72.80%
Change in YoY Net Profit Growth (%)	0.00%	26.33%	31.28%	-63.53%	-20.79%	3.42%	17.47%	-5.16%	-22.25%	14.03%	-11.69%	78.34%

ERIS Lifesciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:	18%
5 Years:	22%
3 Years:	29%
TTM:	30%

Compounded Profit Growth
10 Years:	15%
5 Years:	4%
3 Years:	-5%
TTM:	2%

Stock Price CAGR
10 Years:	Not available
5 Years:	29%
3 Years:	37%
1 Year:	21%

Return on Equity
10 Years:	22%
5 Years:	18%
3 Years:	16%
Last Year:	13%

Last Updated: September 5, 2025, 3:40 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 8, 2026, 8:19 am

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.14	0.14	14	14	14	14	14	14	14	14	14	14
Reserves	266	299	553	848	1,137	1,283	1,563	1,895	2,182	2,573	2,841	3,889
Borrowings	1	0	1	377	176	0	7	84	877	2,781	2,478	2,359
Other Liabilities	91	98	124	170	175	205	202	233	337	1,366	1,415	861
Total Liabilities	357	397	692	1,408	1,502	1,502	1,785	2,226	3,410	6,734	6,747	7,123
Fixed Assets	72	71	232	771	761	875	854	918	2,568	4,319	5,306	5,188
CWIP	0	0	0	0	3	4	2	27	22	20	67	171
Investments	167	190	303	365	356	78	294	520	37	16	67	62
Other Assets	119	136	157	271	383	544	636	761	783	2,379	1,307	1,702
Total Assets	357	397	692	1,408	1,502	1,502	1,785	2,226	3,410	6,734	6,747	7,123

FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	90	131	200	235	223	271	375	378	292	486	1,065	538
Cash from Investing Activity +	-92	-44	-184	-590	-5	123	-323	-320	-975	-1,828	-78	-369
Cash from Financing Activity +	0	-84	-24	363	-221	-335	-82	-45	688	1,380	-881	-314
Net Cash Flow	-2	4	-8	8	-3	60	-30	14	5	38	105	-145
Free Cash Flow	77	108	150	210	186	125	350	258	-550	357	910	241
CFO/OP	96%	97%	94%	94%	85%	87%	103%	94%	68%	87%	114%	59%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	77.00	108.00	150.00	210.00	186.00	125.00	350.00	258.00	-550.00	357.00	910.00	241.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	16	16	16	24	28	31	53	42	44	63	77	58
Inventory Days	166	223	178	195	178	196	148	145	166	136	182	171
Days Payable	138	142	92	134	247	200	213	157	166	129	210	170
Cash Conversion Cycle	43	97	102	84	-40	28	-12	30	44	70	48	59
Working Capital Days	7	15	9	23	-13	-17	59	64	75	50	-296	-49
ROCE %	64%	47%	53%	60%	34%	26%	25%	27%	25%	17%	11%	12%

FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	54.91%	54.90%	54.90%	54.88%	54.87%	54.86%	54.85%	54.83%	54.85%	54.85%	53.92%	54.14%
FIIs	13.20%	13.13%	14.27%	14.59%	8.01%	8.36%	8.43%	8.39%	7.21%	6.85%	6.39%	5.76%
DIIs	14.52%	14.55%	15.63%	16.23%	18.64%	18.07%	18.07%	18.18%	19.36%	20.31%	20.35%	20.71%
Public	17.37%	17.41%	15.20%	14.30%	18.47%	18.73%	18.64%	18.59%	18.57%	17.97%	19.33%	19.39%
No. of Shareholders	42,245	46,496	51,753	44,176	46,346	53,314	50,087	52,225	59,438	54,713	51,656	50,798

Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Small Cap Fund	6,556,651	2.44	901.87	6,506,651	2026-02-23 03:29:50	0.77%
HDFC Hybrid Equity Fund	2,459,629	1.42	338.32	N/A	N/A	N/A
Franklin India Small Cap Fund	1,866,828	2.01	256.78	N/A	N/A	N/A
DSP Small Cap Fund	1,230,000	1.05	169.19	N/A	N/A	N/A
Franklin India Flexi Cap Fund	1,224,569	0.86	168.44	N/A	N/A	N/A
UTI Flexi Cap Fund	1,173,300	0.69	161.39	1,217,751	2026-01-25 07:18:48	-3.65%
HSBC Small Cap Fund	776,897	0.71	106.86	N/A	N/A	N/A
Franklin India Opportunities Fund	771,388	1.28	106.1	N/A	N/A	N/A
UTI Mid Cap Fund	690,000	0.83	94.91	643,678	2026-01-25 07:18:48	7.2%
HDFC Large and Mid Cap Fund	675,000	0.33	92.85	N/A	N/A	N/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Distributions & retention

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	25.85	28.82	28.10	29.89	26.16
Diluted EPS (Rs.)	25.81	28.79	28.07	29.88	26.14
Cash EPS (Rs.)	50.67	42.61	36.12	34.61	29.32
Book Value[Excl.RevalReserv]/Share (Rs.)	209.57	190.11	163.30	140.35	116.10
Book Value[Incl.RevalReserv]/Share (Rs.)	209.57	190.11	163.30	140.35	116.10
Revenue From Operations / Share (Rs.)	212.46	147.70	123.92	99.10	89.25
PBDIT / Share (Rs.)	76.03	51.36	40.29	37.60	32.35
PBIT / Share (Rs.)	52.87	37.94	31.68	32.84	29.19
PBT / Share (Rs.)	35.89	31.70	29.76	32.53	29.05
Net Profit / Share (Rs.)	27.50	29.19	27.51	29.85	26.16
NP After MI And SOA / Share (Rs.)	25.83	28.82	28.10	29.88	26.16
PBDIT Margin (%)	35.78	34.77	32.51	37.93	36.24
PBIT Margin (%)	24.88	25.68	25.56	33.13	32.70
PBT Margin (%)	16.89	21.46	24.01	32.82	32.55
Net Profit Margin (%)	12.94	19.76	22.20	30.12	29.30
NP After MI And SOA Margin (%)	12.15	19.50	22.67	30.14	29.30
Return on Networth / Equity (%)	12.32	15.15	17.40	21.28	22.52
Return on Capital Employeed (%)	12.74	11.42	13.36	21.53	23.76
Return On Assets (%)	5.00	5.56	10.42	17.87	19.35
Long Term Debt / Equity (X)	0.60	0.25	0.29	0.02	0.00
Total Debt / Equity (X)	0.84	1.06	0.37	0.02	0.00
Asset Turnover Ratio (%)	0.41	0.37	0.52	0.61	0.67
Current Ratio (X)	0.88	0.90	1.73	3.14	2.80
Quick Ratio (X)	0.64	0.83	1.43	2.55	2.23
Inventory Turnover Ratio (X)	11.05	1.11	1.26	1.31	1.48
Dividend Payout Ratio (NP) (%)	28.43	0.00	26.15	20.10	21.02
Dividend Payout Ratio (CP) (%)	14.99	0.00	20.01	17.34	18.75
Earning Retention Ratio (%)	71.57	0.00	73.85	79.90	78.98
Cash Earning Retention Ratio (%)	85.01	0.00	79.99	82.66	81.25
Interest Coverage Ratio (X)	4.48	8.24	20.94	123.26	243.78
Interest Coverage Ratio (Post Tax) (X)	2.62	5.68	15.30	98.87	198.08
Enterprise Value (Cr.)	21908.96	13413.39	8575.56	9359.51	8168.96
EV / Net Operating Revenue (X)	7.57	6.68	5.09	6.95	6.74
EV / EBITDA (X)	21.16	19.20	15.65	18.31	18.60
MarketCap / Net Operating Revenue (X)	6.67	5.70	4.62	6.95	6.77
Retention Ratios (%)	71.56	0.00	73.84	79.89	78.97
Price / BV (X)	6.76	4.42	3.54	4.91	5.21
Price / Net Operating Revenue (X)	6.67	5.70	4.62	6.95	6.77
EarningsYield	0.01	0.03	0.04	0.04	0.04